Moroccan Pharmaceutical Industry Teams up with IFC to Cut Carbon Footprints

The Moroccan Federation of Pharmaceuticals Industry and Innovation (FMIIP) has partnered with the International Finance Corporation to enhance the sector’s efficiency and mitigate climate change by reducing water and energy waste.
Under an agreement sealed Tuesday, IFC pledged to help FMIIP members in reducing their carbon and water footprints and improving efficiencies in their production processes.
IFC will share knowledge on best international practices, organize awareness-raising events, and deliver training and capacity building workshops to help boost productivity and ultimately increase the sector’s competitiveness.
“Our partnership with IFC will help local manufacturers strengthen their production capacities and improve their environmental practices. That will also help increase the production of medicines, especially generic ones, in Morocco and North Africa,” said FMIIP’s President, Mohamed El Bouhmadi.
Morocco’s pharmaceuticals sector is currently scaling up efforts to meet the demand for drugs post-pandemic, and help the country meet its target of offering universal health coverage by 2025.
For his part, Manuel Reyes-Retana, IFC’s Regional Director for North Africa, said IFC is stepping up its partnership with key pharma players in the region to create an enabling environment to boost medicine production in Africa.
“Our support to pharmaceutical producers in Morocco will help make the sector more productive and energy-efficient and put manufacturers in a better position to attract investment”, he added.